These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27806788)

  • 1. [Treatment and prognostic analysis of retinoblastoma patients with choroid invasion].
    Wang YZ; Huang DS; Shi JT; Ma JM; Li B; Xu XL; Hu HM; Zhou Y; Gu HL
    Zhonghua Er Ke Za Zhi; 2016 Nov; 54(11):819-822. PubMed ID: 27806788
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic observation of 465 patients with retinoblastoma with optic nerve invasion].
    Wang Y; Huang D; Shi J; Ma J; Zhao J; Li B; Xu X; Hu H; Zhou Y
    Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):109-13. PubMed ID: 25876685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical treatment and prognostic observation for different pathological infiltrations in 537 patients with unilateral retinoblastoma.
    Wang Y; Huang D; Shi J; Ma J; Zhao J; Li B; Xu X; Hu H; Zhou Y; Sun Y
    Chin Med J (Engl); 2014; 127(20):3581-6. PubMed ID: 25316233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of children with retinoblastoma and isolated choroidal invasion.
    Bosaleh A; Sampor C; Solernou V; Fandiño A; Domínguez J; de Dávila MT; Chantada GL
    Arch Ophthalmol; 2012 Jun; 130(6):724-9. PubMed ID: 22801832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
    Chévez-Barrios P; Eagle RC; Krailo M; Piao J; Albert DM; Gao Y; Vemuganti G; Ali MJ; Khetan V; Honavar SG; O'Brien J; Leahey AM; Matthay K; Meadows A; Chintagumpala M
    J Clin Oncol; 2019 Nov; 37(31):2883-2891. PubMed ID: 31539297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution.
    Khelfaoui F; Validire P; Auperin A; Quintana E; Michon J; Pacquement H; Desjardins L; Asselain B; Schlienger P; Vielh P
    Cancer; 1996 Mar; 77(6):1206-13. PubMed ID: 8635145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
    Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
    Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC).
    Alkatan HM; AlQahtani FS; Maktabi AM
    Int Ophthalmol; 2020 Jul; 40(7):1739-1747. PubMed ID: 32193778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma.
    Mustafa MM; Jamshed A; Khafaga Y; Mourad WA; Al-Mesfer S; Kofide A; El-Husseiny G; Gray A
    J Pediatr Hematol Oncol; 1999; 21(5):364-9. PubMed ID: 10524448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?
    Chantada GL; Dunkel IJ; de Dávila MT; Abramson DH
    Br J Ophthalmol; 2004 Aug; 88(8):1069-73. PubMed ID: 15258027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
    Kletke SN; Feng ZX; Hazrati LN; Gallie BL; Soliman SE
    Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of pathologic risk factors in postchemoreduced, enucleated specimens of advanced retinoblastomas in a developing country.
    Suryawanshi P; Ramadwar M; Dikshit R; Kane SV; Kurkure P; Banavali S; Viswanathan S
    Arch Pathol Lab Med; 2011 Aug; 135(8):1017-23. PubMed ID: 21809993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
    Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
    Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors.
    Chong EM; Coffee RE; Chintagumpala M; Hurwitz RL; Hurwitz MY; Chévez-Barrios P
    Arch Pathol Lab Med; 2006 Nov; 130(11):1669-72. PubMed ID: 17076529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
    Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
    Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
    Uusitalo MS; Van Quill KR; Scott IU; Matthay KK; Murray TG; O'Brien JM
    Arch Ophthalmol; 2001 Jan; 119(1):41-8. PubMed ID: 11146725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study on adjuvant chemotherapy in retinoblastoma: validation of the new recommendation against treatment for pT2a tumors based on the 8th AJCC classification.
    Alkatan HM; Almuzaini A; Helmi HA; Maktabi AM
    BMC Ophthalmol; 2024 Jul; 24(1):309. PubMed ID: 39048946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome.
    Cuenca A; Giron F; Castro D; Fandiño A; Guitter M; de Dávila MT; Chantada G
    Arch Ophthalmol; 2009 Aug; 127(8):1006-10. PubMed ID: 19667337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
    Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
    Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoblastoma in Turkey--treatment and prognosis.
    Günalp I; Gündüz K; Arslan Y
    Jpn J Ophthalmol; 1996; 40(1):95-102. PubMed ID: 8739506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.